These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29274334)

  • 21. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
    Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
    Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
    Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A
    Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
    Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
    Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide and Erlotinib loaded in RGD-modified nanoliposomes for targeted combination delivery to PC3 and PANC-1 cell lines.
    Khosravani F; Mir H; Mirzaei A; Kobarfard F; Bardania H; Hosseini E
    Biotechnol Appl Biochem; 2023 Apr; 70(2):811-823. PubMed ID: 36070882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death.
    Park HK; Han BR; Park WH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
    Ghaffari SH; Yousefi M; Dizaji MZ; Momeny M; Bashash D; Zekri A; Alimoghaddam K; Ghavamzadeh A
    Asian Pac J Cancer Prev; 2016; 17(3):1553-64. PubMed ID: 27039805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
    Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
    Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells.
    Li C; Liu Y; Liu H; Zhang W; Shen C; Cho K; Chen X; Peng F; Bi Y; Hou X; Yang Z; Zheng Z; Wang K; Wang X; Zhang J; Zhong C; Zou H; Zhang X; Zhao S
    Cell Physiol Biochem; 2015; 35(4):1303-16. PubMed ID: 25721868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NFκB inhibitors induce cell death in glioblastomas.
    Zanotto-Filho A; Braganhol E; Schröder R; de Souza LH; Dalmolin RJ; Pasquali MA; Gelain DP; Battastini AM; Moreira JC
    Biochem Pharmacol; 2011 Feb; 81(3):412-24. PubMed ID: 21040711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of
    Majkowska-Pilip A; Rius M; Bruchertseifer F; Apostolidis C; Weis M; Bonelli M; Laurenza M; Królicki L; Morgenstern A
    Chem Biol Drug Des; 2018 Jul; 92(1):1344-1356. PubMed ID: 29611298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells.
    Gao JK; Wang LX; Long B; Ye XT; Su JN; Yin XY; Zhou XX; Wang ZW
    Asian Pac J Cancer Prev; 2015; 16(9):3805-10. PubMed ID: 25987041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
    Lam SK; Mak JC; Zheng CY; Li YY; Kwong YL; Ho JC
    Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
    Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
    Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
    Zhao Q; Kretschmer N; Bauer R; Efferth T
    Int J Cancer; 2015 Sep; 137(6):1446-56. PubMed ID: 25688715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.